Test Dec 16
dsm-firmenich plant-based
Home
Videos
IFF: Designing and v...

IFF: Designing and validating clinically relevant probiotic strain combinations

16 Dec 2025 | IFF

Image

IFF’s probiotics portfolio emphasizes clinically studied strain combinations. Johanna Maukonen, global director for clinical innovation and translation, and Jennifer Montgomery, IFF Health Sciences global marketing leader, discussed how IFF approaches designing and validating these formulas to ensure consistent benefits in real-world use, while sharing insights on key advances in the expanding field of probiotics for oral health.

More videos

Image